Subscribe to this blog

Get GeriPal Email Updates

Search This Blog

The Dementia Caregiver: Improving their Mental Health and Quality of Life

There are few harder things than being a caregiver for a
family member with dementia. These caregivers
are the unsung heroes of the US health system.
Because of family caregivers, 2/3 of persons with dementia are able to
continue living at home, often avoiding nursing home care until dementia is very
advanced.

Nursing home care is hugely expensive, and much of the cost
in the US is paid by Medicaid. Next time
you hear about how Medicaid nursing home costs are big contributors to federal
and state budget crises, remember that without caregivers these costs would at
least double.

But while caregivers of dementia patients are unsung heroes,
they are also forgotten heroes. The US
medical system does little to help them.
And they need help. Dementia
caregiving is very stressful and numerous studies have shown negative health
consequences in caregivers. Most
prominent is depression. Caregivers of
dementia patients often meet clinical criteria for a diagnosis of major
depression.

This is what makes a recent study in the British
Medical Journal (BMJ) so important. It shows
that a pragmatic intervention grounded in counseling and psychological support
helps reduce rates of depression in dementia caregivers. The study was led by Dr. Gill Livingston
of University College in London, and based on an intervention protocol
developed by Dr. Delores Gallagher-Thompson of Stanford University.

The study randomized 260 dementia caregivers in London
England to the intervention or usual care.
Most of the caregivers were women (70%), either the spouse or an adult
child.

The intervention consisted of 8 therapy sessions,
usually delivered in the home. A really
neat feature of this intervention: Psychology
graduate students who had no prior clinical experience delivered it. This nicely supports the feasibility of the
intervention as a wide range of persons can be trained to deliver it.

Key features of the intervention, adapted from a manual
developed by Dr. Gallagher Thompson were as follows:

Teaching caregivers about dementia and helping
them understand the behaviors of dementia patients

Discussion of behaviors caregivers found
difficult and training in behavioral management techniques

Teaching the caregiver to incorporate small
pleasant activities into the caregiving day

Caregivers were given “homework” between sessions such as
practicing relaxation techniques, identifying triggers and reactions to
challenging behaviors, and identifying and challenging negative thoughts. The caregiver and therapist both worked from
a manual, which the caregiver filled out over the course of the intervention. The intervention showed the following beneficial effects:

Caregivers who participated in the intervention
had reduced levels of depression and anxiety symptoms

Intervention caregivers reported significantly
better quality of life

The intervention showed a promising trend
towards fewer abusive behaviors directed at the caregiver from the family
member with dementia

If this intervention were a drug, it would be on the fast
track to approval and a pharmaceutical company would be on track to earn
billions of dollars. But alas, it is not
a drug. Therefore, this beneficial
program will not be available to the vast majority of dementia caregivers in
the US.

A note to the Alzheimer’s Association:

Lobbying CMS to pay for this and other proven caregiver
support interventions would be a most worthy use of the Association’s advocacy
efforts. Wouldn’t it be best to focus
the Association’s advocacy efforts on worthy initiatives that will really
benefit Alzheimer patients and caregivers?
This sure seems like a much more worthy advocacy effort than lobbying
CMS to pay thousands of dollars a pop for Amyloid PET Scans.

Shouldn’t we focus on actually helping patients who are
living with dementia right now rather than advocating for expensive high tech
diagnostics that may lead to more harm than benefit? (For more discussion, see Eric Widera's GeriPal post and this excellent commentary in the BMJ)

I am a fellow caregiver and just came across your blog - sorry to see you are in the same position, but if you are anything like me I hope your website provides some sort of outlet...

I have been a young(ish!) carer for my mother-in-law, who suffers from dementia, for the last three years now.

I am in the process of creating a new poetry site primarily aimed at carers, but also people with dementia as well - http://dementiapoetry.com.

The blog is an honest account of my experience of caring over the last few years in poems - some silly, some exasperated, some happy, some sad - of my last three years caring for my mother-in-law, who suffers from Alzheimer's disease, and is aimed at helping to support other caregivers in a similar position.

If you would be happy to link to me, I would gladly return the favour!

Popular posts from this blog

My colleagues often ask me: “Why are Chinese patients so resistant to hospice and palliative care?” “Why are they so unrealistic?” “Don’t they understand that death is part of life?” “Is it true that with Chinese patients you cannot discuss advance directives?”

As a Chinese speaking geriatrician and palliative care physician practicing in Flushing, NY, I have cared for countless Chinese patients with serious illnesses or at end of life. Invariably, when Chinese patients or families see me, they ask me if I speak Chinese. When I reply “I do” in Mandarin, the relief and instant trust I see on their faces make my day meaningful and worthwhile.

At my hospital, the patient population is about 30% Asian, with the majority of these being Chinese. Most of these patients require language interpretation. It becomes an interesting challenge and opportunity, as we often need to discuss advance directives, goals of care, and end of life care options…

In this week's GeriPal podcast we discuss delirium, with a focus on prevention. We are joined by internationally acclaimed delirium researcher Sharon Inouye, MD, MPH. Dr Inouye is Professor of Medicine at Harvard Medical School and Director of the Aging Brain Center in the Institute for Aging Research at Hebrew SeniorLife.

Dr. Inouye's research focuses on delirium and functional decline in hospitalized older patients, resulting in more than 200 peer-reviewed original articles to date. She has developed and validated a widely used tool to identify delirium called the Confusion Assessment Method (CAM), and she founded the Hospital Elder Life Program (HELP) to prevent delirium in hospitalized patients.

We are also joined by guest host Lindsey Haddock, MD, a geriatrics fellow at UCSF who asks a great question about how to implement a HELP program, or aspects of the program, in a hospital with limited resources.

Estimating prognosis is hard and clinicians get very little training on how to do it. Maybe that is one of the reasons that clinicians are more likely to be optimistic and tend to overestimate patient survival by a factor of between 3 and 5. The question is, aren't we better as palliative care clinicians than others in estimating prognosis? This is part of our training and we do it daily. We got to be better, right?

Big findings from this JPSM paper include that we, like all other clinicians, are an optimistic bunch and that it actually does impact outcomes. In particular, the people whose survival was overestimated by a palliative care c…

GeriPal (Geriatrics and Palliative care) is a forum for discourse, recent news and research, and freethinking commentary. Our objectives are: 1) to create an online community of interdisciplinary providers interested in geriatrics or palliative care; 2) to provide an open forum for the exchange of ideas and disruptive commentary that changes clinical practice and health care policy; and 3) to change the world.

No confidential patient information should be placed on GeriPal, nor should any confidential information be placed in the comments. The information provided on GeriPal is designed to complement, not replace, the relationship between a patient and and his/her own medical providers. The editors (Alex Smith and Eric Widera) reserve the right to remove comments that are deemed inappropriate due to the commercial, abusive, or offensive nature of a comment. If you think your comment was deleted for inappropriate reasons, please email either Alex or Eric.

GeriPal's mission is to improve the disemination of information in both geriatics and palliative medicine. GeriPal was created with the support of the Division of Geriatrics at the University of California San Francisco. Its content though is strictly the work of its authors and has no affiliation with or support from any organization or institution. All opinions expressed on this website are solely those of its authors & do not reflect the opinions of any academic institution or medical center. This web site does not accept advertisements. All email addresses collected by GeriPal for feed distribution will be kept confidential and will never be used for commercial reasons. If you reproduce the material on the website please cite appropriately. For questions regarding the site please email Alex Smith, MD (aksmith@ucsf.edu) or Eric Widera, MD (eric.widera@ucsf.edu)